StatLab Medical Products, an Audax Private Equity and Linden Capital Partners portfolio company and a developer of medical diagnostic equipment, has bought CellPath, a manufacturer of products focused on the histology markets. 

The transaction strengthens StatLab’s business for international growth and market expansion.

“We have long respected CellPath for their well-earned reputation of delivering innovative products that solve problems for labs, and are proud to welcome them to the StatLab family of brands,” said Mike Karsonovich, CEO of StatLab. “CellPath’s established European market position and complementary portfolio will empower meaningful international growth in the histology sector.”